Estrogen has been shown to attenuate the inflammatory response following injury or lipopolysaccharide treatment in several organ systems. Estrogen's actions are transduced through two estrogen receptor sub-types, estrogen receptor (ER) -alpha and estrogen receptor-beta, whose actions may be overlapping or independent of each other. The present study examined the effects of ERα-and ERβ-specific ligands in regulating the inflammatory response in primary astrocyte cultures. Pre-treatment with 17β-estradiol (ERα/ERβ agonist), HPTE (ERα agonist/ERβ antagonist) and DPN (ERβ agonist) led to attenuation of IL-1β, TNFα, and MMP-9 in astrocyte media derived from young adult (3-4 mos.) and reproductive senescent female (9-11 mos., acyclic) astrocyte cultures, while pretreatment with PPT (ERα agonist) attenuated IL-1β (but not MMP-9) in both young and senescent-derived astrocyte cultures. Our previous work determined that 17β-estradiol was unable to attenuate the LPSinduced increase in IL-1β in olfactory bulb primary microglial cultures derived from either young adult or reproductive senescent females. In young adult-derived microglial cultures, the LPS-induced increase in IL-1β was not attenuated by pre-treatment with 17β-estradiol, PPT or HPTE. Interestingly, the ERβ agonist, DPN significantly decreased IL-1β following LPS treatment in young adult-derived microglia. Thus while both microglia and astrocytes synthesize and release inflammatory mediators, the present data shows that compounds which bind ERβ are more effective in attenuating proinflammatory cytokines in both cell types and may therefore be a more effective agent for future therapeutic use.
Introduction
Inflammation contributes to the etiology of many neurodegenerative diseases and in women, the risk for such diseases is further affected by the menopause, where ovarian hormones, which are capable of modulating the inflammatory response, are decreased (Andersen et al., 1999; Brann et al., 2007; Gao et al., 1998) . Estrogen has been shown to affect inflammatory mediators such as cytokines in a number of systems and has been shown to decrease inflammation in experimental models of anterior uveitis (Miyamoto et al., 1999) , carrageenan-induced pleurisy in the lungs (Cuzzocrea et al., 2001 (Cuzzocrea et al., , 2000 and adjuvant-induced arthritis (Badger et al., 1999) . On the other hand, estrogen promotes prostatitis (Naslund et al., 1988) , stimulates edema (Tchernitchin and Galand, 1983) and increases vascular permeability and influx of macrophages in the uterus (De and Wood, 1990; Kaushic et al., 1998) . In central nervous system cells, estrogen pretreatment has been shown to attenuate LPS-induced superoxide release, phagocytic activity and an increase in iNOS (Bruce-Keller et al., 2000; Drew and Chavis, 2000; Vegeto et al., 2001 Vegeto et al., , 2000 in microglial cells. Estrogen's actions are transduced through two nuclear receptors estrogen receptor alpha (ERα) (Green et al., 1986; Greene et al., 1986) and estrogen receptor beta (ERβ) (Kuiper et al., 1996) and studies with the ER knockout animals indicate that ERα Journal of Neuroimmunology 195 (2008) 47 -59 www.elsevier.com/locate/jneuroim
